$CGNX
COGNEX CORP

2013 Q1 Form 10-Q Financial Statement

#000119312513182039 Filed on April 29, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q2
Revenue $80.89M $77.71M
YoY Change 4.45%
Cost Of Revenue $19.42M $19.06M
YoY Change 3.58%
Gross Profit $61.47M $58.65M
YoY Change 4.73%
Gross Profit Margin 75.99% 75.48%
Selling, General & Admin $32.17M $30.55M
YoY Change 4.62%
% of Gross Profit 52.33% 52.09%
Research & Development $11.32M $10.36M
YoY Change 9.06%
% of Gross Profit 18.42% 17.67%
Depreciation & Amortization $1.828M $1.551M
YoY Change -35.38%
% of Gross Profit 2.97% 2.64%
Operating Expenses $43.49M $40.91M
YoY Change 5.98%
Operating Profit $17.98M $17.74M
YoY Change 1.96%
Interest Expense $500.0K $300.0K
YoY Change -40.0%
% of Operating Profit 2.78% 1.69%
Other Income/Expense, Net $117.0K $3.000K
YoY Change -101.5%
Pretax Income $18.55M $18.08M
YoY Change 2.14%
Income Tax $2.970M $3.796M
% Of Pretax Income 16.01% 21.0%
Net Earnings $15.58M $14.28M
YoY Change 5.01%
Net Earnings / Revenue 19.26% 18.38%
Basic Earnings Per Share $0.18 $0.34
Diluted Earnings Per Share $0.18 $0.33
COMMON SHARES
Basic Shares Outstanding 86.52M shares 42.57M shares
Diluted Shares Outstanding 88.26M shares 43.59M shares

Balance Sheet

Concept 2013 Q1 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $168.2M $200.8M
YoY Change -3.18%
Cash & Equivalents $42.76M $41.56M
Short-Term Investments $125.4M $159.2M
Other Short-Term Assets $20.10M $28.70M
YoY Change 6.69%
Inventory $26.06M $27.80M
Prepaid Expenses
Receivables $42.78M $45.60M
Other Receivables $0.00 $0.00
Total Short-Term Assets $257.1M $302.9M
YoY Change -0.23%
LONG-TERM ASSETS
Property, Plant & Equipment $34.65M $32.70M
YoY Change 8.64%
Goodwill $81.69M
YoY Change
Intangibles
YoY Change
Long-Term Investments $245.5M $184.0M
YoY Change 68.65%
Other Assets $2.532M $18.30M
YoY Change 5.78%
Total Long-Term Assets $395.4M $335.1M
YoY Change 28.34%
TOTAL ASSETS
Total Short-Term Assets $257.1M $302.9M
Total Long-Term Assets $395.4M $335.1M
Total Assets $652.5M $638.0M
YoY Change 12.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.815M $7.300M
YoY Change -9.88%
Accrued Expenses $24.26M $23.40M
YoY Change -2.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $47.11M $44.30M
YoY Change -17.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.000M $4.900M
YoY Change -10.91%
Total Long-Term Liabilities $6.000M $4.900M
YoY Change -10.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.11M $44.30M
Total Long-Term Liabilities $6.000M $4.900M
Total Liabilities $53.10M $49.20M
YoY Change -16.89%
SHAREHOLDERS EQUITY
Retained Earnings $452.0M
YoY Change
Common Stock $179.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $599.5M $588.8M
YoY Change
Total Liabilities & Shareholders Equity $652.5M $638.0M
YoY Change 12.98%

Cashflow Statement

Concept 2013 Q1 2012 Q2
OPERATING ACTIVITIES
Net Income $15.58M $14.28M
YoY Change 5.01%
Depreciation, Depletion And Amortization $1.828M $1.551M
YoY Change -35.38%
Cash From Operating Activities $18.79M $12.85M
YoY Change -38.2%
INVESTING ACTIVITIES
Capital Expenditures $1.908M $2.487M
YoY Change -255.44%
Acquisitions
YoY Change
Other Investing Activities -$28.40M -$19.50M
YoY Change -19.42%
Cash From Investing Activities -$30.35M -$22.02M
YoY Change -14.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $10.54M 11.67M
YoY Change 64.38%
NET CHANGE
Cash From Operating Activities $18.79M 12.85M
Cash From Investing Activities -$30.35M -22.02M
Cash From Financing Activities $10.54M 11.67M
Net Change In Cash -$1.020M 2.505M
YoY Change 19.29%
FREE CASH FLOW
Cash From Operating Activities $18.79M $12.85M
Capital Expenditures $1.908M $2.487M
Free Cash Flow $16.88M $10.37M
YoY Change -53.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41559000
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
43451932 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
50634000
CY2013Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
364523000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
23.26
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2013Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4321000
CY2013Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2377000
CY2013Q1 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
411000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31867000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
47112000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13769000
CY2013Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
17268000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
452049000
CY2013Q1 us-gaap Assets
Assets
652528000
CY2013Q1 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
1280000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
47243000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42757000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.04
CY2013Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
1069000
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42780000
CY2013Q1 us-gaap Inventory Net
InventoryNet
26057000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000
CY2013Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9787000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3857000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5620604 shares
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2532000
CY2013Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2220000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
652528000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43452000 shares
CY2013Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
125411000
CY2013Q1 us-gaap Goodwill
Goodwill
81689000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1383000 shares
CY2013Q1 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
13819000
CY2013Q1 us-gaap Cost Method Investments
CostMethodInvestments
3740000
CY2013Q1 us-gaap Cash
Cash
32290000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6325000
CY2013Q1 us-gaap Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2
AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2
411000
CY2013Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11949000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
3386000 shares
CY2013Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
5955000
CY2013Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
9398000
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24258000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34647000
CY2013Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
123648000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
87000
CY2013Q1 us-gaap Long Term Investments
LongTermInvestments
245484000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
257099000
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
14025000
CY2013Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
365392000
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
28.22
CY2013Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1247000
CY2013Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
119810000
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179192000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
599461000
CY2013Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13809000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6815000
CY2013Q1 cgnx Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue
26174000
CY2013Q1 cgnx Number Of Stock Option Plans
NumberOfStockOptionPlans
2 OptionPlan
CY2013Q1 cgnx Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
5955000
CY2013Q1 cgnx Number Of Groups Within Employee Population
NumberOfGroupsWithinEmployeePopulation
2 Employees
CY2013Q1 cgnx Employee Service Share Based Compensation Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationRecognizedPeriodCostsCapitalizedAmount
0
CY2013Q1 cgnx Contribution To Limited Partnership
ContributionToLimitedPartnership
19886000
CY2013Q1 cgnx Available For Sale Securities Debt Maturities After Four Years Before Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFourYearsBeforeFiveYearsFairValue
4045000
CY2013Q1 cgnx Available For Sale Securities Debt Maturities After One Year Before Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneYearBeforeTwoYearsFairValue
112310000
CY2013Q1 cgnx Available For Sale Securities Debt Maturities After Three Years Before Four Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsBeforeFourYearsFairValue
13230000
CY2013Q1 cgnx Available For Sale Securities Debt Maturities After Two Years Before Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoYearsBeforeThreeYearsFairValue
112159000
CY2013Q1 cgnx Cash Cash Equivalents Short Term And Long Term Investments
CashCashEquivalentsShortTermAndLongTermInvestments
413652000
CY2013Q1 cgnx Remaining Amount Of Commitment
RemainingAmountOfCommitment
614000
CY2013Q1 cgnx Estimated Forfeiture Rate For Unvested Options For All Non Senior Management
EstimatedForfeitureRateForUnvestedOptionsForAllNonSeniorManagement
0.13 pure
CY2013Q1 cgnx Estimated Forfeiture Rate For Unvested Options For Senior Management
EstimatedForfeitureRateForUnvestedOptionsForSeniorManagement
0.12 pure
CY2013Q1 cgnx Percentage Of Stock Options Granted To All Other Employees Expected To Vest
PercentageOfStockOptionsGrantedToAllOtherEmployeesExpectedToVest
0.69 pure
CY2013Q1 cgnx Percentage Of Stock Options Granted To Senior Management Expected To Vest
PercentageOfStockOptionsGrantedToSeniorManagementExpectedToVest
0.71 pure
CY2013Q1 cgnx Stock Repurchased To Date Two Thousand Eight Plan
StockRepurchasedToDateTwoThousandEightPlan
1375875 shares
CY2013Q1 cgnx Stock Repurchased Value To Date Two Thousand Eight Plan
StockRepurchasedValueToDateTwoThousandEightPlan
30000000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38103000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4193000
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2256000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29515000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50104000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14394000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15647000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
436466000
CY2012Q4 us-gaap Assets
Assets
627605000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45160000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.56
CY2012Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
5076000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42387000
CY2012Q4 us-gaap Inventory Net
InventoryNet
26182000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1131000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9322000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3559000 shares
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2827000
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1009000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
627605000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43055000 shares
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
105105000
CY2012Q4 us-gaap Goodwill
Goodwill
81689000
CY2012Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
12690000
CY2012Q4 us-gaap Cost Method Investments
CostMethodInvestments
3740000
CY2012Q4 us-gaap Cash
Cash
34986000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6369000
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12667000
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
5216000
CY2012Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
5098000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29590000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34820000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
86000
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
238255000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
239597000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
165248000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
572285000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14770000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6815000
CY2012Q4 cgnx Employee Service Share Based Compensation Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationRecognizedPeriodCostsCapitalizedAmount
0
CY2012Q4 cgnx Cash Cash Equivalents Short Term And Long Term Investments
CashCashEquivalentsShortTermAndLongTermInvestments
388520000
CY2010Q3 cgnx Number Of Companys Patents Found Invalid
NumberOfCompanysPatentsFoundInvalid
2 Patents
CY2008Q2 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
50000000
CY2011Q4 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
80000000
CY2009Q3 cgnx Number Of Respondents With Whom Settlement Was Reached
NumberOfRespondentsWithWhomSettlementWasReached
2 Respondent
CY2009Q4 cgnx Number Of Respondents With Whom Settlement Was Reached
NumberOfRespondentsWithWhomSettlementWasReached
5 Respondent
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000851205
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Trading Symbol
TradingSymbol
CGNX
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
COGNEX CORP
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
117000
CY2013Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-227000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1371000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18553000
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
397000 shares
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30354000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
23.10
CY2013Q1 us-gaap Product Warranty Accrual Currency Translation Increase Decrease
ProductWarrantyAccrualCurrencyTranslationIncreaseDecrease
-62000
CY2013Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9168000
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11321000
CY2013Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
658000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43261000 shares
CY2013Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
88000 shares
CY2013Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
860000
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.16 pure
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2494000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6220000
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
76694000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
42.11
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2403000
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.17 pure
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17981000
CY2013Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1094000
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3298000
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19423000
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.03 pure
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2013Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
48248000
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1376000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2013Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
392000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
227000
CY2013Q1 us-gaap Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
63000
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44130000 shares
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
16464000
CY2013Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-758000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
15583000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
783000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.021 pure
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10544000
CY2013Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax
31000
CY2013Q1 us-gaap Cost Of Services
CostOfServices
2959000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.42 pure
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
869000 shares
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
50000
CY2013Q1 us-gaap Gross Profit
GrossProfit
61469000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13262000
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32167000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2970000
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1383000
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
63000
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9168000
CY2013Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3298000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1908000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
80892000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1376000
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
961000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
74672000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
31.79
CY2013Q1 us-gaap Depreciation
Depreciation
1828000
CY2013Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.00
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3298000
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
482969 shares
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18790000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.13
CY2013Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
173000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2321000
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.01 pure
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
42000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2013Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
475000
CY2013Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
31000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1376000
CY2013Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
19000
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.02 pure
CY2013Q1 cgnx Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue
6932000
CY2013Q1 cgnx Investment Expiration Date
InvestmentExpirationDate
2013-12-31
CY2013Q1 cgnx Adjustment To Additional Paid In Capital Tax Benefit For Research And Development Credits As Result Of Stock Option Accounting
AdjustmentToAdditionalPaidInCapitalTaxBenefitForResearchAndDevelopmentCreditsAsResultOfStockOptionAccounting
-103000
CY2013Q1 cgnx Reserve For Income Taxes To Be Recorded In Additional Paid In Capital
ReserveForIncomeTaxesToBeRecordedInAdditionalPaidInCapital
405000
CY2013Q1 cgnx Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value
SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue
7193000
CY2013Q1 cgnx Minimum Decrease In Income Tax Expense Due To Release In Reserves
MinimumDecreaseInIncomeTaxExpenseDueToReleaseInReserves
1600000
CY2013Q1 cgnx Maximum Decrease In Income Tax Expense Due To Release In Reserves
MaximumDecreaseInIncomeTaxExpenseDueToReleaseInReserves
1800000
CY2013Q1 cgnx Maximum Investment In Limited Partnership
MaximumInvestmentInLimitedPartnership
20500000
CY2013Q1 cgnx Increase In Liability Net Of Deferred Tax Benefit For Uncertain Tax Positions
IncreaseInLiabilityNetOfDeferredTaxBenefitForUncertainTaxPositions
644000
CY2013Q1 cgnx Increase Decrease Interest And Penalties
IncreaseDecreaseInterestAndPenalties
38000
CY2013Q1 cgnx Gross Margin Products
GrossMarginProducts
58208000
CY2013Q1 cgnx Gross Margin Services
GrossMarginServices
3261000
CY2013Q1 cgnx Income Tax Examination Years Under Examination Other Entities
IncomeTaxExaminationYearsUnderExaminationOtherEntities
2006 through 2012
CY2013Q1 cgnx Opened Tax Years By Major Tax Jurisdiction
OpenedTaxYearsByMajorTaxJurisdiction
2008 through 2012
CY2013Q1 cgnx Effective Income Tax Rate Continuing Operations Excluding Impact Of Discrete Event
EffectiveIncomeTaxRateContinuingOperationsExcludingImpactOfDiscreteEvent
0.19 pure
CY2013Q1 cgnx Other Comprehensive Income Loss Reclassification Adjustment For Realized Gain Loss On Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRealizedGainLossOnSaleOfSecuritiesIncludedInNetIncomeNetOfTax
31000
CY2012Q1 cgnx Other Comprehensive Income Loss Reclassification Adjustment For Realized Gain Loss On Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForRealizedGainLossOnSaleOfSecuritiesIncludedInNetIncomeNetOfTax
94000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
206000
CY2012Q2 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
179000
CY2012Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22020000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10361000
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42570000 shares
CY2012Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
6060000
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5326000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18078000
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6302000
CY2012Q2 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
56721000
CY2012Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3456000
CY2012Q2 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.15 pure
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17741000
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1087000
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19058000
CY2012Q2 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
pure
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2012Q2 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
37188000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
15556000
CY2012Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1835000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
14282000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2012Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
972000
CY2012Q2 us-gaap Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
-638000
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43590000 shares
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11671000
CY2012Q2 us-gaap Cost Of Services
CostOfServices
3502000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.44 pure
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1020000 shares
CY2012Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
94000
CY2012Q2 us-gaap Gross Profit
GrossProfit
58651000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20922000
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-638000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30549000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3796000
CY2012Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
951000
CY2012Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13104000
CY2012Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3314000
CY2012Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2487000
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
77709000
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2838000
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1043000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
71407000
CY2012Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4271000
CY2012Q2 us-gaap Depreciation
Depreciation
1551000
CY2012Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3314000
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
802048 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.98
CY2012Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1314000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6640000
CY2012Q2 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
pure
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
291000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.012 pure
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12854000
CY2012Q2 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
94000
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
2838000
CY2012Q2 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.01 pure
CY2012Q2 cgnx Share Based Compensation Arrangement By Share Based Payment Award Options Vested Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedFairValue
6399000
CY2012Q2 cgnx Shares Based Compensation Arrangement By Shares Based Payment Award Options Exercisable Intrinsic Value
SharesBasedCompensationArrangementBySharesBasedPaymentAwardOptionsExercisableIntrinsicValue
12636000
CY2012Q2 cgnx Gross Margin Products
GrossMarginProducts
55851000
CY2012Q2 cgnx Gross Margin Services
GrossMarginServices
2800000

Files In Submission

Name View Source Status
0001193125-13-182039-index-headers.html Edgar Link pending
0001193125-13-182039-index.html Edgar Link pending
0001193125-13-182039.txt Edgar Link pending
0001193125-13-182039-xbrl.zip Edgar Link pending
cgnx-20130331.xml Edgar Link completed
cgnx-20130331.xsd Edgar Link pending
cgnx-20130331_cal.xml Edgar Link unprocessable
cgnx-20130331_def.xml Edgar Link unprocessable
cgnx-20130331_lab.xml Edgar Link unprocessable
cgnx-20130331_pre.xml Edgar Link unprocessable
d490913d10q.htm Edgar Link pending
d490913dex311.htm Edgar Link pending
d490913dex312.htm Edgar Link pending
d490913dex321.htm Edgar Link pending
d490913dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending